|
MARS is a Recovery Community Support Program Grantee
|
MARS is a Recovery Community Support Program Grantee
Saturday, October 16, 2004 Preconference Events Frederick W. Christie, MA AFIRM Long Island, New York H. Westley Clark, MD, JD, MPH CSAT Rockville, MD Stewart Leavitt, PHD Addiction Treatment Forum Glenview, IL James P. Connolly, CMA PA NAMA Newtown, PA Herman Joseph, PHD, CMA NAMA New York, NY J. Thomas Payte, MD, CMA Colonial Management…
DOJ publishes guidance on Opioid Use Disorder and the Americans with Disabilities Act April 15, 2022 “The opioid crisis poses an extraordinary challenge to communities throughout our country. The Department of Justice (the Department) has responded with a comprehensive approach prioritizing prevention, enforcement, and treatment. This includes enforcing the Americans with Disabilities Act (Ada), which…
National Alliance of Methadone Advocates The Pharmacology of Methadone Ignorance about methadone abounds. Professionals working in the field receive very little or no training at all about the very medication that they will be administering. Rarely is addiction viewed as a disease and under the domain of the medical profession. Even the medical profession does…
Methadone Advocacy The National Alliance of Methadone Advocates (NAMA) holds the view that every individual who believes in methadone treatment is at least a potential Certified Methadone Advocate (CMA). We encourage all supporters of methadone treatment, patient and non-patient, to become Certified Methadone Advocates so that all energies directed toward the advancement of methadone treatment…
Conference 2000 American Methadone Treatment Association April 9-12, 2000 San Francisco Committee Chair John Finger Committee Members Assistant to the Chair, Michael Garrett Co-chair, Alice Diorio Committee James DePasquale Becky Duarte Barbara Finger Carlos Franco Greg Keller Howard Lotsof Judith Ostergard Carmen Pearman Diane Seaman Joycelyn Woods NAMA Events and Activities Exhibition Booth Booth Manager:…
National Methadone Conference AMTA 2001 Sunday, October 7th The Advocate’sIllumination Award is presented to an individual and/or treatment program whose persistence in the search of solutions to the myriad problems of addictive disease, has significantly improved the experience and outcome of treatment. Inscription The Opioid Agonist Treatment Advocacy Community with heartfelt thanks and admiration is…